India to Australia: Fexofenadine Export Trade Route
India has recorded 504 verified shipments of Fexofenadine exported to Australia, representing a combined trade value of $8.8M USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $17.5K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 26% of total export value with 218 shipments worth $2.3M USD. On the buying side, NOUMED PHARMACEUTICALS PTY LTD is the largest importer in Australia with $1.9M USD in purchases. The top 3 suppliers — CIPLA LIMITED, IND SWIFT LIMITED, MEDREICH LIMITED — together control 53% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Fexofenadine corridor is one of India's established pharmaceutical export routes, with 504 shipments documented worth a combined $8.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's fexofenadine manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $17.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with fexofenadine's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #14 among India's top fexofenadine export destinations globally.
On the import side, key buyers of Indian fexofenadine in Australia include NOUMED PHARMACEUTICALS PTY LTD, APOTEX PTY LTD, NOUMED PHARMACEUTICALS PTY LTD and 25 others. NOUMED PHARMACEUTICALS PTY LTD is the single largest importer with 182 shipments valued at $1.9M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ4
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#14
- Annual growth+28.2%
- Demand growth+23.7%
- Regulatory ease89/100
Top 10 Indian Fexofenadine Exporters to Australia
Showing top 10 of 15 Indian suppliers exporting Fexofenadine to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $10.6K per shipment | 218 | $2.3M | 26.1% |
| 2 | IND SWIFT LIMITED Avg $30.4K per shipment | 42 | $1.3M | 14.5% |
| 3 | MEDREICH LIMITED Avg $19.3K per shipment | 55 | $1.1M | 12.0% |
| 4 | CADILA PHARMACEUTICALS LIMITED Avg $41.8K per shipment | 23 | $961.9K | 10.9% |
| 5 | CIPLA LIMITED Avg $13.4K per shipment | 65 | $871.6K | 9.9% |
| 6 | IND SWIFT LIMITED Avg $63.5K per shipment | 12 | $762.4K | 8.6% |
| 7 | MEDREICH LIMITED Avg $16.2K per shipment | 40 | $647.5K | 7.3% |
| 8 | IND-SWIFT LIMITED Avg $35.9K per shipment | 7 | $251.2K | 2.8% |
| 9 | IND-SWIFT LTD Avg $27.0K per shipment | 7 | $188.9K | 2.1% |
| 10 | DR.REDDY'S LABORATORIES LTD Avg $14.0K per shipment | 11 | $154.0K | 1.7% |
This table shows the top 10 of 15 Indian companies exporting fexofenadine to Australia, ranked by total trade value. The listed exporters are: CIPLA LIMITED, IND SWIFT LIMITED, MEDREICH LIMITED, CADILA PHARMACEUTICALS LIMITED, CIPLA LIMITED , IND SWIFT LIMITED , MEDREICH LIMITED , IND-SWIFT LIMITED, IND-SWIFT LTD, DR.REDDY'S LABORATORIES LTD . CIPLA LIMITED is the dominant supplier with 218 shipments worth $2.3M USD, giving it a 26% market share. The top 3 suppliers together account for 53% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to Australia Fexofenadine export route.
Top 10 Fexofenadine Importers in Australia
Showing top 10 of 28 known buyers in Australia receiving Fexofenadine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fexofenadine in Australia include NOUMED PHARMACEUTICALS PTY LTD, APOTEX PTY LTD, NOUMED PHARMACEUTICALS PTY LTD , MEDREICH AUSTRALIA PTY LTD, APOTEX PTY LTD. , among 28 total buyers. The largest importer is NOUMED PHARMACEUTICALS PTY LTD, accounting for $1.9M USD across 182 shipments — representing 22% of all fexofenadine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NOUMED PHARMACEUTICALS PTY LTD | 182 | $1.9M | 21.7% |
| 2 | APOTEX PTY LTD | 42 | $1.2M | 13.8% |
| 3 | NOUMED PHARMACEUTICALS PTY LTD | 65 | $871.6K | 9.9% |
| 4 | MEDREICH AUSTRALIA PTY LTD | 37 | $756.1K | 8.6% |
| 5 | APOTEX PTY LTD. | 10 | $682.4K | 7.7% |
| 6 | MEDREICH AUSTRALIA PTY LTD | 38 | $608.6K | 6.9% |
| 7 | ARROW PHARMACEUTICALS PTY LTD | 7 | $435.3K | 4.9% |
| 8 | ARROW PHARMACEUTICALS PTY LTD. | 13 | $380.3K | 4.3% |
| 9 | APOTEX PTY LIMITED | 11 | $376.6K | 4.3% |
| 10 | NOUMED PHARMACEUTICALS PTY LIMITED | 28 | $204.0K | 2.3% |
Showing top 10 of 28 Fexofenadine importers in Australia on this route.
Top 10 Fexofenadine Formulations Imported by Australia
Showing top 10 of 274 product formulations shipped on the India to Australia Fexofenadine route, ranked by trade value
Australia imports a wide range of fexofenadine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TERRY WHITE CHEMMART FEXOFENADINE HAYFEV — accounts for $806.2K USD across 60 shipments. There are 274 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TERRY WHITE CHEMMART FEXOFENADINE HAYFEV | 60 | $806.2K | 9.1% |
| 2 | APO HEALTH FEXOFENADINE 180 Mg(Fexofenad | 7 | $554.9K | 6.3% |
| 3 | CHEMISTS OWN FEXO 180MG TABLET (R/M : FEXOFENADINE HYDROCHLORIDE) BATCH BY05E4009 TO BY05E4016 (ASPERINV) | 3 | $173.2K | 2.0% |
| 4 | FEXOFENADINE HYDROCHLORIDE 180MG TABS ( | 5 | $139.5K | 1.6% |
| 5 | FEXOFENADINE HYDROCHLORIDE TABLETS 180MG | 9 | $133.2K | 1.5% |
| 6 | APO HEALTH FEXOFENADINE HAYFEVER & ALLERGY RELIEF,BT#AHC10725B,AHC10825 TO AHC11125,(7X10T) PACKS-35950X7X10T=2516500** | 1 | $124.4K | 1.4% |
| 7 | TERRY WHITE CHEMMART FEXOFENADINE HAYFEV | 12 | $110.4K | 1.3% |
| 8 | CHEMISTS OWN FEXO 180 50 TABLETS R M FEXOFENADINE HYDROCHLORIDE BATCH BY05E5015 TO BY05E5019 AS PER INVOICE | 1 | $109.7K | 1.2% |
| 9 | APO HEALTH FEXOFENADINE 180MG FEXOFENADINE HYDROCH TABLETS USP 180MG 26360X70 1845200 NOS | 1 | $107.5K | 1.2% |
| 10 | FEXOFENADINE HYDROCHLORIDE TABLETS 180MGPRICELINE PHARMACY FEXOFENADINE HAYFEVER&ALLERGY RELIEF 180MG7X10S31806PACKS | 1 | $96.6K | 1.1% |
Showing top 10 of 274 Fexofenadine formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 100 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's fexofenadine exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 218 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, IND SWIFT LIMITED, MEDREICH LIMITED — together account for 53% of total trade value on this route. The average shipment value of $17.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as apo health fexofenadine 180 mg(fexofenad and chemists own fexo 180mg tablet (r/m : fexofenadine hydrochloride) batch by05e4009 to by05e4016 (asperinv), suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NOUMED PHARMACEUTICALS PTY LTD is the largest importer with 182 shipments worth $1.9M USD — representing 22% of all fexofenadine imports from India on this route. A total of 28 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $8.8M
- Avg. Shipment
- $17.5K
- Suppliers
- 15
- Buyers
- 28
- Transit (Sea)
- ~15 days
- Annual Growth
- +28.2%
Related Analysis
Reverse Direction
Australia → India — Fexofenadine (Import)Other Fexofenadine Routes
Unlock the Full India to Australia Fexofenadine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 504 shipments on this route.
Frequently Asked Questions — India to Australia Fexofenadine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fexofenadine to Australia?
The leading Indian exporters of Fexofenadine to Australia are CIPLA LIMITED, IND SWIFT LIMITED, MEDREICH LIMITED. CIPLA LIMITED holds the largest market share at approximately 26% of total trade value on this route.
Q What is the total value of Fexofenadine exports from India to Australia?
India exports Fexofenadine to Australia worth approximately $8.8M USD across 504 recorded shipments. The average value per shipment is $17.5K USD.
Q Which ports does India use to ship Fexofenadine to Australia?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 100 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Australia for Fexofenadine?
The average transit time for Fexofenadine shipments from India to Australia is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Fexofenadine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.2% with demand growth tracking at 23.7%. The route is ranked #14 among India's top Fexofenadine export destinations globally.
Q How many suppliers are active on the India to Australia Fexofenadine route?
There are currently 15 active Indian suppliers exporting Fexofenadine to Australia. The market is moderately concentrated with CIPLA LIMITED accounting for 26% of total shipment value.
Q Who are the main importers of Fexofenadine from India in Australia?
The leading importers of Indian Fexofenadine in Australia include NOUMED PHARMACEUTICALS PTY LTD, APOTEX PTY LTD, NOUMED PHARMACEUTICALS PTY LTD , MEDREICH AUSTRALIA PTY LTD, APOTEX PTY LTD. . NOUMED PHARMACEUTICALS PTY LTD is the largest buyer with 182 shipments worth $1.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Fexofenadine.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 28 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 504 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
504 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists